Advertisement

Topics

Daniel Ronel, M.D. Company Profile

00:44 EST 23rd November 2017 | BioPortfolio


News Articles [118 Associated News Articles listed on BioPortfolio]

Author Daniel Hamby’s Newly Released “The Battle Wagon And Other Stories” Is a Collection of Stories That Reveals the Helping Hand of God

(PRWEB) September 05, 2017 “The Battle Wagon And Other Stories”: a collection of stories to inspire those lost in troubled...

e-Therapeutics: Daniel Elger. Pioneers of network pharmacology, a distinctive new approach to the discovery of medicines

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Daniel Elger, CFO at e-Therapeutics.

Merck-Aktie: Schwache Quartalszahlen erwartet - Kursziel gesenkt - Aktienanalyse

Frankfurt - Merck-Aktienanalyse von Aktienanalyst Daniel Wendorff von der Commerzbank: Daniel Wendorff, Aktienanalyst der Commerzbank, senkt in einer aktuellen Aktienanalyse vor Zahlen sein Kurszie...

Merck-Aktie: Prüfung verschiedener Optionen für Consumer-Health-Sparte vernünftig! Aktienanalyse

Frankfurt - Merck-Aktienanalyse von Analyst Daniel Wendorff von der Commerzbank: Daniel Wendorff, Analyst der Commerzbank, hält in einer aktuellen Aktienanalyse angesichts der Unternehmensüberlegun....

QIAGEN-Aktie: Sehr solide Quartalszahlen - Kaufempfehlung bestätigt - Aktienanalyse

Frankfurt - QIAGEN-Aktienanalyse von Aktienanalyst Daniel Wendorff von der Commerzbank: Daniel Wendorff, Aktienanalyst der Commerzbank, rät in einer aktuellen Aktienanalyse nach Q3-Zahlen weiterhin.....

Merck-Aktie: Stabile Entwicklung im Pharmageschäft bis 2020 erwartet - Aktienanalyse

Frankfurt - Merck-Aktienanalyse von Analyst Daniel Wendorff von der Commerzbank: Daniel Wendorff, Analyst der Commerzbank, hält in einer aktuellen Aktienanalyse an seinem bisherigen Anlagevotum für....

Gerresheimer-Aktie: Ausblick zu ambitioniert! Aktienanalyse

London - Gerresheimer-Aktienanalyse von Analyst Daniel Grigat von HSBC: Daniel Grigat, Analyst von HSBC, hält in einer aktuellen Aktienanalyse nach Q3-Zahlen an seinem bisherigen Anlagevotum für di....

STADA-Aktie: Wieder auf Fundamentaldaten schauen! Aktienanalyse

Frankfurt - STADA-Aktienanalyse von Analyst Daniel Wendorff von der Commerzbank: Daniel Wendorff, Analyst der Commerzbank, hält in einer aktuellen Aktienanalyse nach der fehlgeschlagenen Übernahme ....

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Quik gel [Cinogen Cosmetics Zhaoqing, LTD.]

Quik Gel Advanced Hand Sanitizing Gel Singles

Quik spray [Cinogen Cosmetics Zhaoqing, LTD.]

QuikSpray Advanced Hand Sanitizing Spray

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Review of "Medical Error-the Third Leading Cause of Death in the US" by Makary MA and Daniel M in BMJ 353: i2139, 2016.

Correction: Synthesis and X-ray structural characterization of the (chlorochalcogeno)phosphonium cations R2R'PSCl(+) and R2R'PSeCl(+) as their AuCl4(-) salts.

Correction for 'Synthesis and X-ray structural characterization of the (chlorochalcogeno)phosphonium cations R2R'PSCl(+) and R2R'PSeCl(+) as their AuCl4(-) salts' by Daniel Upmann and Peter G. Jones, ...

Flowers for Algernon: The ethics of human experimentation on the intellectually disabled.

Flowers for Algernon is a novel written in 1966 by Daniel Keyes. Since its publication, it has received significant critical acclaim, earning a Nebula science-fiction award, and was also adapted into ...

The evolution of stories: from mimesis to language, from fact to fiction.

Why a species as successful as Homo sapiens should spend so much time in fiction, in telling one another stories that neither side believes, at first seems an evolutionary riddle. Because of the advan...

Are thermal barriers "higher" in deep sea turtle nests?

Thermal tolerances are affected by the range of temperatures that species encounter in their habitat. Daniel Janzen hypothesized in his "Why mountain passes are higher in the tropics" that temperature...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

This study intends to compare novel antipsychotics ziprasidone and olanzapine, to confirm the findings of an open study -where stable patients receiving olanzapine switched to ziprasidone-...

Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model

Aim of the study: Evaluation of feasibility, safety and potential effects of stem cells on chronic wounds using a pressure sore model. Clinical relevance: - Accelerated h...

PET Scanning in Parkinson's Disease

This is an in vivo positron emission tomography (PET) study of regional cerebral dopamine neurochemistry and blood flow in normal volunteers, persons with Parkinson's disease (both familia...

Companies [37 Associated Companies listed on BioPortfolio]

Daniel Ronel, M.D.

Jack Daniel Distillery

Officially registered by the U.S. Government in 1866 and based in Lynchburg, Tenn., the Jack Daniel Distillery, Lem Motlow, proprietor, is the oldest registered distillery in the ...

Daniel J. Edelman, Inc.

Dr. Daniel Shapiro

Daniel Memorial, Inc.

More Information about "Daniel Ronel, M.D." on BioPortfolio

We have published hundreds of Daniel Ronel, M.D. news stories on BioPortfolio along with dozens of Daniel Ronel, M.D. Clinical Trials and PubMed Articles about Daniel Ronel, M.D. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Daniel Ronel, M.D. Companies in our database. You can also find out about relevant Daniel Ronel, M.D. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record